The global Sinus Dilation Device market size is expected to reach USD 8.6 billion by 2030 and is expected to expand at a CAGR of 15.0% from 2021 to 2030.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38414
Growth Factors
Increasing cases of obesity, and a resultant rise in the incidence of sinus-related conditions are the major factors contributing to the market growth. The introduction of technologically advanced devices is also one of the key factors boosting market growth. Major market players are focusing on R&D activities to introduce minimally invasive procedures creating a positive impact on the adoption of MIS procedures.
Some of the inventions in the market related to endoscopic approaches include a nasal endoscope, rhinoscopes, and balloon sinus dilation devices. An increase in medical reimbursements across major markets is likely to fuel the market growth. Rising adoption of and growing per capita expenditure coupled in developed as well as developing countries is predicted to augment the market growth.
Report Highlights
The Balloon Sinus Dilation (BSD) devices segment captured the largest revenue share of more than 57% in 2020. BSDs are safe, small, flexible, and effective in improving symptoms of sinusitis. As sinus dilation procedure does not involve tissue ablation, it results in quick turnaround time and patient comfort. However, BSD procedures are temporary, and patients may have to go for repeat procedures.
The standalone procedure segment captured the highest revenue share of over 78% in 2020. Balloon sinus ostial dilation is performed as a standalone procedure. Standalone balloon dilation is as effective as functional endoscopic sinus surgery for treating chronic rhinosinusitis. In addition, the rising preference for minimally invasive surgical procedures due to increased adoption of health insurance is anticipated to fuel segment growth.
The hospitals segment accounted for the largest revenue share of over 61% in 2020 and is expected to witness considerable growth during the forecast period owing to the high volume of surgical procedures performed in hospitals. The increasing prevalence of chronic sinusitis coupled with favorable reimbursement criteria is anticipated to boost the segment growth. The availability of technologically advanced infrastructure and medical equipment along with the ability to perform complex sinus surgeries are projected to boost segment growth.
The adult patient segment accounted for the highest revenue share of more than 78% in 2020 owing to the high prevalence of sinusitis in adults. For instance, in September 2017, according to the CDC, sinusitis is more common in adults than in children. 9 out of 10 viral sinusitis cases in adults were observed in the U.S.
North America captured the largest market share of more than 50% in 2020 and is expected to continue its dominance over the forecast period. The dominance can be attributed to the presence of highly regulated and developed healthcare infrastructure. Moreover, the availability of advanced products due to the presence of major market players is boosting the market growth. Asia Pacific is projected to exhibit the fastest CAGR over the forecast period owing to an increase in disposable income and improvement in patient awareness about sinus surgical procedures.
| Report Coverage | Details |
| Market Size | US$ 8.6 billion by 2030 |
| Growth Rate | CAGR of 15.0% From 2021 to 2030 |
| Base Year | 2020 |
| Historic Data | 2017 to 2020 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Product, Procedure, Application, End use |
| Regional Scope | North America, Latin America, Europe, Asia Pacific, MEA |
| Companies Mentioned | Stryker; Smith & Nephew; Olympus Corp.; Medtronic |
Key Players
- Stryker
- Smith & Nephew
- Olympus Corporation
- Medtronic
Market Segmentation
- Product Outlook
- Balloon Sinus Dilation Devices
- Endoscopes
- Functional Endoscopic Sinus Surgery (FESS) Instruments Set
- Sinus Stents/Implants
- Others
- Procedure Outlook
- Standalone
- Hybrid
- Application Outlook
- Adult
- Pediatric
- End-use Outlook
- Hospitals
- ENT Clinics/In-office
- Ambulatory Surgical Centers (ASCs)
- Regional Outlook
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Asia Pacific
- Japan
- China
- India
- Malaysia
- Australia
- Latin America
- Brazil
- Mexico
- Argentina
- Chile
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- North America
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38414
Reasons to Purchase this Report:
– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Sinus Dilation Device Market, By Product
7.1. Sinus Dilation Device Market, by Product, 2020-2030
7.1.1. Balloon Sinus Dilation Devices
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Endoscopes
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Functional Endoscopic Sinus Surgery (FESS) Instruments Set
7.1.3.1. Market Revenue and Forecast (2016-2030)
7.1.4. Sinus Stents/Implants
7.1.4.1. Market Revenue and Forecast (2016-2030)
7.1.5. Others
7.1.5.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Sinus Dilation Device Market, By Procedure
8.1. Sinus Dilation Device Market, by Procedure, 2020-2030
8.1.1. Standalone
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Hybrid
8.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Sinus Dilation Device Market, By End User
9.1. Sinus Dilation Device Market, by End User, 2020-2030
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. ENT Clinics/In-office
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Ambulatory Surgical Centers (ASCs)
9.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Sinus Dilation Device Market, By Application
10.1. Sinus Dilation Device Market, by Application, 2020-2030
10.1.1. Adult
10.1.1.1. Market Revenue and Forecast (2016-2030)
10.1.2. Pediatric
10.1.2.1. Market Revenue and Forecast (2016-2030)
Chapter 11. Global Sinus Dilation Device Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2016-2030)
11.1.2. Market Revenue and Forecast, by Procedure (2016-2030)
11.1.3. Market Revenue and Forecast, by End User (2016-2030)
11.1.4. Market Revenue and Forecast, by Application (2016-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.1.5.2. Market Revenue and Forecast, by Procedure (2016-2030)
11.1.5.3. Market Revenue and Forecast, by End User (2016-2030)
11.1.5.4. Market Revenue and Forecast, by Application (2016-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.1.6.2. Market Revenue and Forecast, by Procedure (2016-2030)
11.1.6.3. Market Revenue and Forecast, by End User (2016-2030)
11.1.6.4. Market Revenue and Forecast, by Application (2016-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.2. Market Revenue and Forecast, by Procedure (2016-2030)
11.2.3. Market Revenue and Forecast, by End User (2016-2030)
11.2.4. Market Revenue and Forecast, by Application (2016-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.5.2. Market Revenue and Forecast, by Procedure (2016-2030)
11.2.5.3. Market Revenue and Forecast, by End User (2016-2030)
11.2.5.4. Market Revenue and Forecast, by Application (2016-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.6.2. Market Revenue and Forecast, by Procedure (2016-2030)
11.2.6.3. Market Revenue and Forecast, by End User (2016-2030)
11.2.6.4. Market Revenue and Forecast, by Application (2016-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.7.2. Market Revenue and Forecast, by Procedure (2016-2030)
11.2.7.3. Market Revenue and Forecast, by End User (2016-2030)
11.2.7.4. Market Revenue and Forecast, by Application (2016-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Product (2016-2030)
11.2.8.2. Market Revenue and Forecast, by Procedure (2016-2030)
11.2.8.3. Market Revenue and Forecast, by End User (2016-2030)
11.2.8.4. Market Revenue and Forecast, by Application (2016-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.2. Market Revenue and Forecast, by Procedure (2016-2030)
11.3.3. Market Revenue and Forecast, by End User (2016-2030)
11.3.4. Market Revenue and Forecast, by Application (2016-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.5.2. Market Revenue and Forecast, by Procedure (2016-2030)
11.3.5.3. Market Revenue and Forecast, by End User (2016-2030)
11.3.5.4. Market Revenue and Forecast, by Application (2016-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.6.2. Market Revenue and Forecast, by Procedure (2016-2030)
11.3.6.3. Market Revenue and Forecast, by End User (2016-2030)
11.3.6.4. Market Revenue and Forecast, by Application (2016-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.7.2. Market Revenue and Forecast, by Procedure (2016-2030)
11.3.7.3. Market Revenue and Forecast, by End User (2016-2030)
11.3.7.4. Market Revenue and Forecast, by Application (2016-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Product (2016-2030)
11.3.8.2. Market Revenue and Forecast, by Procedure (2016-2030)
11.3.8.3. Market Revenue and Forecast, by End User (2016-2030)
11.3.8.4. Market Revenue and Forecast, by Application (2016-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.2. Market Revenue and Forecast, by Procedure (2016-2030)
11.4.3. Market Revenue and Forecast, by End User (2016-2030)
11.4.4. Market Revenue and Forecast, by Application (2016-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.5.2. Market Revenue and Forecast, by Procedure (2016-2030)
11.4.5.3. Market Revenue and Forecast, by End User (2016-2030)
11.4.5.4. Market Revenue and Forecast, by Application (2016-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.6.2. Market Revenue and Forecast, by Procedure (2016-2030)
11.4.6.3. Market Revenue and Forecast, by End User (2016-2030)
11.4.6.4. Market Revenue and Forecast, by Application (2016-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.7.2. Market Revenue and Forecast, by Procedure (2016-2030)
11.4.7.3. Market Revenue and Forecast, by End User (2016-2030)
11.4.7.4. Market Revenue and Forecast, by Application (2016-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Product (2016-2030)
11.4.8.2. Market Revenue and Forecast, by Procedure (2016-2030)
11.4.8.3. Market Revenue and Forecast, by End User (2016-2030)
11.4.8.4. Market Revenue and Forecast, by Application (2016-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.5.2. Market Revenue and Forecast, by Procedure (2016-2030)
11.5.3. Market Revenue and Forecast, by End User (2016-2030)
11.5.4. Market Revenue and Forecast, by Application (2016-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Product (2016-2030)
11.5.5.2. Market Revenue and Forecast, by Procedure (2016-2030)
11.5.5.3. Market Revenue and Forecast, by End User (2016-2030)
11.5.5.4. Market Revenue and Forecast, by Application (2016-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Product (2016-2030)
11.5.6.2. Market Revenue and Forecast, by Procedure (2016-2030)
11.5.6.3. Market Revenue and Forecast, by End User (2016-2030)
11.5.6.4. Market Revenue and Forecast, by Application (2016-2030)
Chapter 12. Company Profiles
12.1. Stryker
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Smith & Nephew
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Olympus Corporation
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Medtronic
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38414
Contact Us:
Vision Research Reports
Call: +1 9197 992 333
